Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk R Schultz

Showing results (101-110 of 217) with videos related to

Pageof 22
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2010
Unrelated donor bone marrow transplantation for myelodysplastic syndrome in childrenPaul Woodard, Paul A Carpenter, Stella M Davies, et al.
JNCI Cancer Spectrum|April 13, 2019
Tumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric MalignanciesAmanda Lorentzian, Jaclyn A Biegel, D Gigi Ostrow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 12, 2015
Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802Shernan G Holtan, Michael R Verneris, Kirk R Schultz, et al.
Blood Advances|November 2, 2022
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHDNataliya P Buxbaum, Gerard Socié, Geoffrey R Hill, et al.
Pediatric Blood & Cancer|September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reductionNirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Canadian Journal of Kidney Health and Disease|March 9, 2017
Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort StudyKelly R McMahon, Shahrad Rod Rassekh, Kirk R Schultz, et al.
British Journal of Haematology|January 25, 2020
Experience with ponatinib in paediatric patients with leukaemiaJenna Rossoff, Van Huynh, Rachel E Rau, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Abstracts of the Cell Therapy Transplant Canada 2022 Annual ConferenceStephanie A Maier, Tobias Berg, Susan Berrigan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group reportPaul J Martin, Daniel Weisdorf, Donna Przepiorka, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for DevelopmentDennis Dong Hwan Kim, Gizelle Popradi, Kylie Lepic, et al.
Pageof 22

Showing results (101-110 of 217) with videos related to

Sort By:
Pageof 22
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2010
Unrelated donor bone marrow transplantation for myelodysplastic syndrome in childrenPaul Woodard, Paul A Carpenter, Stella M Davies, et al.
JNCI Cancer Spectrum|April 13, 2019
Tumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric MalignanciesAmanda Lorentzian, Jaclyn A Biegel, D Gigi Ostrow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 12, 2015
Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802Shernan G Holtan, Michael R Verneris, Kirk R Schultz, et al.
Blood Advances|November 2, 2022
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHDNataliya P Buxbaum, Gerard Socié, Geoffrey R Hill, et al.
Pediatric Blood & Cancer|September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reductionNirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Canadian Journal of Kidney Health and Disease|March 9, 2017
Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort StudyKelly R McMahon, Shahrad Rod Rassekh, Kirk R Schultz, et al.
British Journal of Haematology|January 25, 2020
Experience with ponatinib in paediatric patients with leukaemiaJenna Rossoff, Van Huynh, Rachel E Rau, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Abstracts of the Cell Therapy Transplant Canada 2022 Annual ConferenceStephanie A Maier, Tobias Berg, Susan Berrigan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group reportPaul J Martin, Daniel Weisdorf, Donna Przepiorka, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for DevelopmentDennis Dong Hwan Kim, Gizelle Popradi, Kylie Lepic, et al.
Pageof 22